Methylphenidate hydrochloride and Sleep walking - a phase IV clinical study of FDA data

Summary:

Sleep walking is reported as a side effect among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride), especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months also take Xyrem, and have Drowsiness.

The phase IV clinical study analyzes which people have Sleep walking when taking Methylphenidate hydrochloride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Methylphenidate hydrochloride from the FDA, and is updated regularly.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,823 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.

What is Sleep walking?

Sleep walking (walking during sleep) is found to be associated with 676 drugs and 1,125 conditions by eHealthMe. Check the latest studies of Sleep walking.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

6,364 people reported to have side effects when taking Methylphenidate hydrochloride.
Among them, 30 people (0.47%) have Sleep walking.

Could Methylphenidate hydrochloride cause Sleep walking?

Among these 30 people:

How long have people been on Methylphenidate hydrochloride when they have Sleep walking? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Sleep walking when taking Methylphenidate hydrochloride? *

  • female: 72.41 %
  • male: 27.59 %

What is the age of people who have Sleep walking when taking Methylphenidate hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 7.14 %
  • 10-19: 35.71 %
  • 20-29: 21.43 %
  • 30-39: 14.29 %
  • 40-49: 21.43 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Methylphenidate hydrochloride? *

  1. Xyrem: 17 people, 56.67%
  2. Singulair: 9 people, 30.00%
  3. Abilify: 7 people, 23.33%
  4. Magnesium: 7 people, 23.33%
  5. Adderall: 6 people, 20.00%
  6. Acetylsalicylic Acid: 5 people, 16.67%
  7. Melatonin: 5 people, 16.67%
  8. Xolair: 5 people, 16.67%
  9. Wellbutrin: 5 people, 16.67%
  10. Ventolin: 5 people, 16.67%

What are other side effects people have besides Sleep walking? *

  1. Insomnia (sleeplessness): 14 people, 46.67%
  2. Sleep-Related Eating Disorder (abnormal eating patterns during the night): 9 people, 30.00%
  3. Tardive Dyskinesia (a disorder that involves involuntary movements): 8 people, 26.67%
  4. Oral Herpes (viral infection of mouth): 7 people, 23.33%
  5. Panic Disorder: 7 people, 23.33%
  6. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 7 people, 23.33%
  7. Night Sweats (sweating in night): 7 people, 23.33%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 23.33%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 23.33%
  10. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 6 people, 20.00%

What are the existing conditions these people have? *

  1. Drowsiness: 10 people, 33.33%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 30.00%
  3. Bipolar Disorder (mood disorder): 7 people, 23.33%
  4. Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 16.67%
  5. Rapid Eye Movements Sleep Abnormal: 5 people, 16.67%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 16.67%
  7. Hypersensitivity: 5 people, 16.67%
  8. Asthma: 5 people, 16.67%
  9. Migraine (headache): 1 person, 3.33%
  10. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate hydrochloride and have Sleep walking?

- Check whether Sleep walking is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylphenidate hydrochloride:

Sleep walking treatments and more:

How severe was Sleep walking and when was it recovered:

Expand to all the drugs that have ingredients of methylphenidate hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sleep walking:

Browse all the conditions that are associated with Sleep walking:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Methylphenidate hydrochloride) and Methylphenidate hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: